Larvol Delta - Revolution-Medicinesannounced-that-theFDA-has-granted-Breakthrough-Therapy-Designation-to-RASONQUE-daraxonrasibfor-treatmentna239ve-metastatic-pancreatic-adenocarcinoma-PDAC-in-combination-with-gemcitabine-and-nabpaclitaxel-GnP

Rasonque (daraxonrasib) - Revolution Medicines

https://www.globenewswire.com/news-release/2026/09/14/3361540/0/en/revolution-medicines-announces-u-s-fda-breakthrough-therapy-designation-for-rasonque-daraxonrasib-in-combination-with-chemotherapy-for-first-line-metastatic-pancreatic-cancer.html

Sep 14, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next